Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds

Colin R. Butler, Robert E. Hynds, Claire Crowley, Kate H C Gowers, Leanne Partington, Nicholas J. Hamilton, Carla Carvalho, Manuela Platé, Edward R. Samuel, Alan J. Burns, Luca Urbani, Martin A. Birchall, Mark W. Lowdell, Paolo De Coppi, Sam M. Janes

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Patients with large tracheal lesions unsuitable for conventional endoscopic or open operations may require a tracheal replacement but there is no present consensus of how this may be achieved. Tissue engineering using decellularized or synthetic tracheal scaffolds offers a new avenue for airway reconstruction. Decellularized human donor tracheal scaffolds have been applied in compassionate-use clinical cases but naturally derived extracellular matrix (ECM) scaffolds demand lengthy preparation times. Here, we compare a clinically applied detergent-enzymatic method (DEM) with an accelerated vacuum-assisted decellularization (VAD) protocol. We examined the histological appearance, DNA content and extracellular matrix composition of human donor tracheae decellularized using these techniques. Further, we performed scanning electron microscopy (SEM) and biomechanical testing to analyze decellularization performance. To assess the biocompatibility of scaffolds generated using VAD, we seeded scaffolds with primary human airway epithelial cells in vitro and performed in vivo chick chorioallantoic membrane (CAM) and subcutaneous implantation assays. Both DEM and VAD protocols produced well-decellularized tracheal scaffolds with no adverse mechanical effects and scaffolds retained the capacity for in vitro and in vivo cellular integration. We conclude that the substantial reduction in time required to produce scaffolds using VAD compared to DEM (approximately 9 days vs. 3–8 weeks) does not compromise the quality of human tracheal scaffold generated. These findings might inform clinical decellularization techniques as VAD offers accelerated scaffold production and reduces the associated costs.

Original languageEnglish (US)
Pages (from-to)95-105
Number of pages11
JournalBiomaterials
Volume124
DOIs
StatePublished - Apr 1 2017
Externally publishedYes

Fingerprint

Vacuum
Scaffolds
Tissue
Detergents
Extracellular Matrix
Compassionate Use Trials
Tissue Donors
Scaffolds (biology)
Chorioallantoic Membrane
Tissue Engineering
Trachea
Electron Scanning Microscopy
Epithelial Cells
Costs and Cost Analysis
Biocompatibility
Tissue engineering
DNA
Assays
Membranes
Scanning electron microscopy

Keywords

  • Epithelial cells
  • Tissue engineering
  • Tissue scaffolds
  • Trachea
  • Transplantation

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Butler, C. R., Hynds, R. E., Crowley, C., Gowers, K. H. C., Partington, L., Hamilton, N. J., ... Janes, S. M. (2017). Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds. Biomaterials, 124, 95-105. https://doi.org/10.1016/j.biomaterials.2017.02.001

Vacuum-assisted decellularization : an accelerated protocol to generate tissue-engineered human tracheal scaffolds. / Butler, Colin R.; Hynds, Robert E.; Crowley, Claire; Gowers, Kate H C; Partington, Leanne; Hamilton, Nicholas J.; Carvalho, Carla; Platé, Manuela; Samuel, Edward R.; Burns, Alan J.; Urbani, Luca; Birchall, Martin A.; Lowdell, Mark W.; De Coppi, Paolo; Janes, Sam M.

In: Biomaterials, Vol. 124, 01.04.2017, p. 95-105.

Research output: Contribution to journalArticle

Butler, CR, Hynds, RE, Crowley, C, Gowers, KHC, Partington, L, Hamilton, NJ, Carvalho, C, Platé, M, Samuel, ER, Burns, AJ, Urbani, L, Birchall, MA, Lowdell, MW, De Coppi, P & Janes, SM 2017, 'Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds', Biomaterials, vol. 124, pp. 95-105. https://doi.org/10.1016/j.biomaterials.2017.02.001
Butler, Colin R. ; Hynds, Robert E. ; Crowley, Claire ; Gowers, Kate H C ; Partington, Leanne ; Hamilton, Nicholas J. ; Carvalho, Carla ; Platé, Manuela ; Samuel, Edward R. ; Burns, Alan J. ; Urbani, Luca ; Birchall, Martin A. ; Lowdell, Mark W. ; De Coppi, Paolo ; Janes, Sam M. / Vacuum-assisted decellularization : an accelerated protocol to generate tissue-engineered human tracheal scaffolds. In: Biomaterials. 2017 ; Vol. 124. pp. 95-105.
@article{961d55ea597e43dfaad1eab56557d619,
title = "Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds",
abstract = "Patients with large tracheal lesions unsuitable for conventional endoscopic or open operations may require a tracheal replacement but there is no present consensus of how this may be achieved. Tissue engineering using decellularized or synthetic tracheal scaffolds offers a new avenue for airway reconstruction. Decellularized human donor tracheal scaffolds have been applied in compassionate-use clinical cases but naturally derived extracellular matrix (ECM) scaffolds demand lengthy preparation times. Here, we compare a clinically applied detergent-enzymatic method (DEM) with an accelerated vacuum-assisted decellularization (VAD) protocol. We examined the histological appearance, DNA content and extracellular matrix composition of human donor tracheae decellularized using these techniques. Further, we performed scanning electron microscopy (SEM) and biomechanical testing to analyze decellularization performance. To assess the biocompatibility of scaffolds generated using VAD, we seeded scaffolds with primary human airway epithelial cells in vitro and performed in vivo chick chorioallantoic membrane (CAM) and subcutaneous implantation assays. Both DEM and VAD protocols produced well-decellularized tracheal scaffolds with no adverse mechanical effects and scaffolds retained the capacity for in vitro and in vivo cellular integration. We conclude that the substantial reduction in time required to produce scaffolds using VAD compared to DEM (approximately 9 days vs. 3–8 weeks) does not compromise the quality of human tracheal scaffold generated. These findings might inform clinical decellularization techniques as VAD offers accelerated scaffold production and reduces the associated costs.",
keywords = "Epithelial cells, Tissue engineering, Tissue scaffolds, Trachea, Transplantation",
author = "Butler, {Colin R.} and Hynds, {Robert E.} and Claire Crowley and Gowers, {Kate H C} and Leanne Partington and Hamilton, {Nicholas J.} and Carla Carvalho and Manuela Plat{\'e} and Samuel, {Edward R.} and Burns, {Alan J.} and Luca Urbani and Birchall, {Martin A.} and Lowdell, {Mark W.} and {De Coppi}, Paolo and Janes, {Sam M.}",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.biomaterials.2017.02.001",
language = "English (US)",
volume = "124",
pages = "95--105",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Vacuum-assisted decellularization

T2 - an accelerated protocol to generate tissue-engineered human tracheal scaffolds

AU - Butler, Colin R.

AU - Hynds, Robert E.

AU - Crowley, Claire

AU - Gowers, Kate H C

AU - Partington, Leanne

AU - Hamilton, Nicholas J.

AU - Carvalho, Carla

AU - Platé, Manuela

AU - Samuel, Edward R.

AU - Burns, Alan J.

AU - Urbani, Luca

AU - Birchall, Martin A.

AU - Lowdell, Mark W.

AU - De Coppi, Paolo

AU - Janes, Sam M.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Patients with large tracheal lesions unsuitable for conventional endoscopic or open operations may require a tracheal replacement but there is no present consensus of how this may be achieved. Tissue engineering using decellularized or synthetic tracheal scaffolds offers a new avenue for airway reconstruction. Decellularized human donor tracheal scaffolds have been applied in compassionate-use clinical cases but naturally derived extracellular matrix (ECM) scaffolds demand lengthy preparation times. Here, we compare a clinically applied detergent-enzymatic method (DEM) with an accelerated vacuum-assisted decellularization (VAD) protocol. We examined the histological appearance, DNA content and extracellular matrix composition of human donor tracheae decellularized using these techniques. Further, we performed scanning electron microscopy (SEM) and biomechanical testing to analyze decellularization performance. To assess the biocompatibility of scaffolds generated using VAD, we seeded scaffolds with primary human airway epithelial cells in vitro and performed in vivo chick chorioallantoic membrane (CAM) and subcutaneous implantation assays. Both DEM and VAD protocols produced well-decellularized tracheal scaffolds with no adverse mechanical effects and scaffolds retained the capacity for in vitro and in vivo cellular integration. We conclude that the substantial reduction in time required to produce scaffolds using VAD compared to DEM (approximately 9 days vs. 3–8 weeks) does not compromise the quality of human tracheal scaffold generated. These findings might inform clinical decellularization techniques as VAD offers accelerated scaffold production and reduces the associated costs.

AB - Patients with large tracheal lesions unsuitable for conventional endoscopic or open operations may require a tracheal replacement but there is no present consensus of how this may be achieved. Tissue engineering using decellularized or synthetic tracheal scaffolds offers a new avenue for airway reconstruction. Decellularized human donor tracheal scaffolds have been applied in compassionate-use clinical cases but naturally derived extracellular matrix (ECM) scaffolds demand lengthy preparation times. Here, we compare a clinically applied detergent-enzymatic method (DEM) with an accelerated vacuum-assisted decellularization (VAD) protocol. We examined the histological appearance, DNA content and extracellular matrix composition of human donor tracheae decellularized using these techniques. Further, we performed scanning electron microscopy (SEM) and biomechanical testing to analyze decellularization performance. To assess the biocompatibility of scaffolds generated using VAD, we seeded scaffolds with primary human airway epithelial cells in vitro and performed in vivo chick chorioallantoic membrane (CAM) and subcutaneous implantation assays. Both DEM and VAD protocols produced well-decellularized tracheal scaffolds with no adverse mechanical effects and scaffolds retained the capacity for in vitro and in vivo cellular integration. We conclude that the substantial reduction in time required to produce scaffolds using VAD compared to DEM (approximately 9 days vs. 3–8 weeks) does not compromise the quality of human tracheal scaffold generated. These findings might inform clinical decellularization techniques as VAD offers accelerated scaffold production and reduces the associated costs.

KW - Epithelial cells

KW - Tissue engineering

KW - Tissue scaffolds

KW - Trachea

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=85012065418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012065418&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2017.02.001

DO - 10.1016/j.biomaterials.2017.02.001

M3 - Article

C2 - 28189871

AN - SCOPUS:85012065418

VL - 124

SP - 95

EP - 105

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -